Juan J. Arroyo‐Crespo

Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression

Juan J. Arroyo‐Crespo, Ana Armiñán, David Charbonnier et al. · International Journal of Cancer · 2019 · 121 citations · Full text

Metastatic Progression, Breast Oncology, Tumor Heterogeneity +14

Tumor microenvironment-targeted poly-L-glutamic acid-based combination conjugate for enhanced triple negative breast cancer treatment

Juan J. Arroyo‐Crespo, Ana Armiñán, David Charbonnier et al. · Biomaterials · 2018 · 73 citations · Full text

Polyglutamic acid-based crosslinked doxorubicin nanogels as an anti-metastatic treatment for triple negative breast cancer

Aroa Duro‐Castaño, Ana Sousa‐Herves, Ana Armiñán et al. · Journal of Controlled Release · 2021 · 59 citations · Full text

Nanomedicine, Oncology, Engineering +10

Capturing “Extraordinary” Soft‐Assembled Charge‐Like Polypeptides as a Strategy for Nanocarrier Design

Aroa Duro‐Castaño, Vicent J. Nebot, Amaya Niño‐Pariente et al. · Advanced Materials · 2017 · 54 citations · Full text

Nanomedicine, Engineering, Polymer Nanotechnology +15

Anticancer Activity Driven by Drug Linker Modification in a Polyglutamic Acid‐Based Combination‐Drug Conjugate

Juan J. Arroyo‐Crespo, Coralie Deladriere, Vicent J. Nebot et al. · Advanced Functional Materials · 2018 · 46 citations · Full text

Pharmaceutical Science, Nanotherapeutics, Conjugate Family Member +23